Alumni Ventures

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in major cities across North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies with an alumni connection and supported by established institutional lead investors. Alumni Ventures aims to provide accredited investors, particularly alumni from top entrepreneurial schools, with access to diversified venture portfolios that span various sectors and geographic regions. The firm typically invests between $0.01 million and $3 million and does not require board or observer seats in its portfolio companies. Through its managed fund families, Alumni Ventures enables investors to participate in a collaborative investment approach, fostering connections among alumni while facilitating investment opportunities in innovative ventures.

Rob Adams

Managing Partner

Gail Ball

Venture Scout

Andrew Baum

Vice President, Treasury and Capital Management

David Beazley

Executive Partner

Ali Byrd

Investor Advisory Council Member

Matt Caspari

Managing Partner, Strawberry Creek and amp; Deep Tech

Matt Castellini

Senior Associate

Helen Chen

CEO Services Analyst

Cainon Coates

Managing Partner

Michael Collins

CEO

Thomas Edwards

Associate

Yev Gelfand

Investor

Mason Hale

Senior Associate, Chestnut Street and Triphammer Ven

Jin Kim

Senior Vice President, Office of Investments

Lucas Kirshenbaum

VC Investor

Ron Levin

Managing Partner, AV Seed Fund and Doctors Innovate Fund

Jess Liu-Brown

Principal

Michael Madden

Co-Founder and Investment Professionals

Jonathan Meltzer

Managing Partner

Tom Meyer

Managing Partner, Nassau Street

Keith Murphy

Director, Video Programs

David Muson

CFO

Aisha Robinson

Comms Team VP of Strategic Communications

Saad Shaheen

Investor Operations Manager

Stephen Stolzenberg

Senior Associate

Justin Strausbaugh

Managing Partner, Lakeshore

Brittney Wade

Senior Associate, Seed Fund

Sarah Worden

Venture Scout

Wesley Yiu

Partner

Henri Yuan

Investor

Michael Yuann

Director of Investment Operations

Past deals in Health Diagnostics

Dropstat

Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.

PathSpot

Series A in 2022
PathSpot Technologies, Inc. is a New York City-based company that develops a system designed to protect food service establishments and their customers from food-borne illnesses. Founded in 2017, PathSpot's technology scans employees' hands to detect harmful pathogens in under two seconds, utilizing a unique algorithm that filters, processes, and analyzes fluorescent light. In addition to hand scanning, the device can also indicate the presence of harmful bacteria on work surfaces and cooking utensils, allowing clients to quickly identify and mitigate threats. By providing reliable and efficient pathogen detection, PathSpot aims to enhance food safety and safeguard both patrons and employees.

Remedial Health

Seed Round in 2022
Remedial Health is a company focused on enhancing access to medicines for healthcare retail businesses, including large pharmacies and small chemist shops. By utilizing advanced technology, it develops a pharmacy operations and procurement management platform that facilitates direct ordering from manufacturers and registered distributors. This platform supports both large and small retailers in streamlining their dispensing and workflow management processes, ensuring just-in-time stock availability. Additionally, Remedial Health provides financing options and a diverse selection of inventory, thereby improving the efficiency and effectiveness of medicine procurement for its clients.

Nanopath

Series A in 2022
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Moving Analytics

Series A in 2022
Moving Analytics. is a tele-health company dedicated to helping people thrive after heart disease. Our flagship product is Movn a virtual cardiac rehabilitation program that leverages evidence based guidelines, behavioral science, remote monitoring and personalized coaching to help patients recover to full health after a cardiac event. Movn is currently used by the Veterans Affairs Medical Center, Highmark Health Plan, Kaiser Permanente Northwest and many more health systems across the US.

Magnetic Insight

Series B in 2022
Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), a novel imaging modality that detects iron oxide nanoparticle tracers using time-varying magnetic fields. The company has developed several key products, including the MOMENTUM imager, a pre-clinical MPI solution that produces detailed images through advanced reconstruction techniques, and VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies. Additionally, the company offers Hyper, a module for localized magnetic hyperthermia, and Relax, which focuses on particle relaxometry. Founded in 2012 and based in Alameda, California, Magnetic Insight is dedicated to enhancing preclinical diagnostics and research by enabling quantitative cell tracking, imaging vascular functions, and detecting metastatic tumors, thereby addressing significant challenges in clinical and translational research.

Swing Therapeutics

Series A in 2022
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

Titan

Seed Round in 2022
Aware Healthcare is a VC-backed digital healthcare startup on a mission to build the “thermometer for the mind”: a digital medical device that delivers real-time measures of clinical risk at the moments patients and providers need it most. We envision a world where we all have the self-awareness to identify when we’re heading down a dark path, vocabulary to describe how we’re mentally feeling, and tools to get help in minutes not weeks.

Quadrant Health

Pre Seed Round in 2022
Quadrant Health, founded in 2021 by Krishna Gorrepati and Anin Sayana, specializes in providing real-time analysis of electronic health records (EHR) and patient messaging data. The company has developed a cloud-based disease prediction platform that employs machine learning algorithms to identify potential health risks, such as infections and injuries, before symptoms manifest. This innovative approach enables healthcare providers to proactively manage patient care, enhancing their ability to prevent harm and improve overall patient outcomes. By focusing on early detection, Quadrant Health aims to transform preventative medicine and support healthcare professionals in delivering more effective care.

Miga

Seed Round in 2022
Miga is a virtual cardiometabolic clinic that focuses on improving heart health through an innovative platform that combines gamified mobile applications with comprehensive clinical services. Founded by Jarrad Aguirre, MD, and Dre Limberopoulos, Miga's offerings include at-home monitoring for blood pressure, telemedicine consultations, mail-order pharmacy services, and lifestyle coaching. The clinic addresses various cardiometabolic conditions such as obesity, hypertension, diabetes, and hyperlipidemia, empowering patients to manage their health effectively and reduce the risk of serious heart issues, including premature heart attacks and strokes.

Legacy

Series B in 2022
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.

Legion Health

Seed Round in 2022
Legion Health operates a platform that connects telehealth companies with a network of highly-vetted clinicians, facilitating access to mental health services. By leveraging artificial intelligence, Legion Health streamlines the psychiatric care process, allowing healthcare organizations to efficiently scale their virtual behavioral health offerings. The platform enables patients to receive timely care from qualified providers while minimizing the administrative burdens often faced by clinicians. This approach not only enhances the patient experience but also allows healthcare organizations to meet growing demands for mental health services in a more effective manner.

Satellite Bio

Series A in 2022
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.

Epicore Biosystems

Series A in 2022
Epicore Biosystems, Inc. has developed a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance and nutrition. Epicore's wearable sensing technology is based on over two decades of microfluidics and soft materials research by Prof. John Rogers and Prof. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Biolectronics.

Iterative Scopes

Series B in 2022
Iterative Scopes, Inc. is a Boston-based company founded in 2017 that specializes in developing machine learning-powered diagnostic tools for gastroenterologists aimed at preventing colon cancer. The company utilizes computer vision and machine learning technologies to provide real-time computer-aided detection and diagnostic tools, which enhance the ability of doctors to detect and categorize lesions during procedures. These tools are designed to improve patient outcomes by identifying lesions that may be missed by the human eye. Additionally, Iterative Scopes offers access to deep neural networks trained by experienced gastrointestinal specialists, thereby expanding the availability of advanced diagnostic capabilities for healthcare providers globally.

Luma Health

Series C in 2021
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.

GRO Biosciences

Series A in 2021
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.

Insiteflow

Seed Round in 2021
Insiteflow is a company based in Austin, Texas, that specializes in an integrated electronic health record (EHR) platform designed to enhance clinical decision-making. Founded in 2018 by Anthony Gerardi and Corey Hall, the platform aims to improve clinical workflows by providing point-of-care insights that support better decision-making and treatment planning for patients. Insiteflow's technology focuses on automating EHR workflows to increase user adoption, efficiency, and effectiveness, while also capturing the decisions made by clinicians and staff within EHR databases. This approach allows healthcare professionals to drive improvements at critical decision points, ultimately transforming the results and return on investment from existing analytics and EHR systems.

Gordy Health

Convertible Note in 2021
Gordy Health is a virtual care provider exclusively focused on blood pressure management to lower patients’ risk for heart attack, stroke, and kidney failure. The company aims to prevent complications from high blood pressure to have healthier lives and live longer. Gordy Health was founded in 2021 and is based in Pasadena, California.

Evernow

Convertible Note in 2021
Developer of an online teleconsultation platform designed to guide women during and after menopause. The company's platform has online access to specialized doctors, science-backed pieces of information and treatments with conversations and information about effective care for changing hormones, enabling women to live longer and healthier lives.

Olaris

Series B in 2021
Olaris, Inc. is a biotechnology company based in Waltham, Massachusetts, focused on developing a precision medicine diagnostic platform aimed at improving disease diagnosis and treatment. Founded in 2013, Olaris specializes in metabolite profiling and personalized biomarkers of response, utilizing advanced machine learning algorithms. This innovative approach allows healthcare providers to identify the most effective treatments for individual patients, thereby optimizing clinical outcomes and minimizing adverse effects associated with therapies. Through its metabolomics platform, Olaris seeks to transform the way diseases, particularly breast cancer, are diagnosed and managed.

GritWell

Seed Round in 2021
GritWell Ltd is a digital health platform that connects patients with chronic health conditions to a network of nutritionists, health coaches, and various types of doctors, including functional, holistic, and naturopathic practitioners. The platform facilitates secure video consultations and direct messaging, allowing users to receive credible health advice and personalized long-term treatment plans. Additionally, GritWell offers referrals for further diagnostic testing, enhancing the continuity of care for patients. For healthcare practitioners, the platform provides a comprehensive dashboard to efficiently manage their practice, featuring tools for online scheduling, patient records, conversation notes, and treatment plans. Founded in 2018, GritWell is headquartered in San Francisco, California.

Health Hero

Seed Round in 2021
Health Hero, Inc. is a wellness platform provider that offers customized health solutions for employees and their families globally. Founded in 2014 and based in Tampa, Florida, the company connects users through mobile devices and computers to deliver health risk assessments, biometric screenings, and cultural assessments. The platform targets various industries and promotes employee engagement by incorporating gamification elements, allowing users to earn rewards for completing health-related tasks. Additionally, Health Hero facilitates automated follow-up communications via phone and text, catering to the needs of payers, providers, employers, and individuals. By focusing on social determinants of health, Health Hero aims to foster a healthier lifestyle for its users through personalized and accessible programming.

Kenshō Health

Seed Round in 2021
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.

AdaptX

Series A in 2021
AdaptX operates a healthcare data analytics platform that focuses on delivering automated analytics to frontline clinical staff. Founded in 2016 and based in Seattle, the company emerged from Seattle Children's Hospital and serves hospitals and surgery centers. Through its innovative solutions, AdaptX empowers medical leaders and clinicians to access and analyze data effectively, enabling them to enhance clinical and workflow outcomes. This approach not only improves patient care but also helps reduce costs, thereby transforming clinical operations within the healthcare sector.

BetterYou

Venture Round in 2021
BetterYou is a digital wellness platform that empowers both individuals and organizations to enhance health and well-being through data-driven insights. By utilizing data generated from daily interactions with its devices, BetterYou helps users identify where they spend their time compared to what truly matters to them. The platform encourages users to define their own criteria for "time better spent," allowing them to focus on their personal wellness goals across physical, mental, social, and educational dimensions. Additionally, BetterYou provides organizations with population-level insights that facilitate improved employee wellness, ultimately driving health savings and fostering healthier habits within the workforce.

Asto CT

Series B in 2021
Asto CT LLC specializes in developing X-ray computed tomography (CT) systems specifically for equine imaging, aimed at enhancing the care and safety of thoroughbreds, show, recreational, and older horses. Founded in 2015 and based in Madison, Wisconsin, the company offers advanced imaging solutions that improve fracture risk detection, diagnose lameness, and address dental and sinus issues without the need for general anesthesia. Their flagship product, Equina, provides rapid 3D imaging of horses' lower limbs, head, and neck while ensuring a safe and comfortable environment for the animals. By integrating cutting-edge robotics with advanced multi-slice CT technology, Asto CT enhances veterinary diagnostics and treatment, particularly for conditions affecting the distal limb and diseases of the head and neck.

SHINE Technologies

Series C in 2021
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

Zone7

Convertible Note in 2021
The future of human performance starts now. Zone7 is used by more than 30 professional sports franchises to track performance and injury risk of some of the world’s leading athletes. Zone7 is also being used to monitor the physical wellbeing of medical staffs in leading hospitals around the world. By analyzing data from wearables, video cameras, medical records and various biomechanics metrics, Zone7 provides coaching staffs and hospital administrators with actionable advice to positively influence rest, work assignment, and planning to protect and optimize human performance.

Veralox Therapeutics

Series A in 2021
Veralox Therapeutics specializes in the development of small molecule therapeutics aimed at addressing the underlying causes of thrombosis and type one diabetes. By leveraging a deep understanding of the molecular mechanisms associated with these conditions, the company seeks to create innovative treatment options that can lead to improved health outcomes for patients. Their focus includes therapies specifically targeting heparin-induced thrombocytopenia and thrombosis, with the goal of providing patients with effective solutions for complete recovery from diabetes and associated complications.

Insiteflow

Seed Round in 2021
Insiteflow is a company based in Austin, Texas, that specializes in an integrated electronic health record (EHR) platform designed to enhance clinical decision-making. Founded in 2018 by Anthony Gerardi and Corey Hall, the platform aims to improve clinical workflows by providing point-of-care insights that support better decision-making and treatment planning for patients. Insiteflow's technology focuses on automating EHR workflows to increase user adoption, efficiency, and effectiveness, while also capturing the decisions made by clinicians and staff within EHR databases. This approach allows healthcare professionals to drive improvements at critical decision points, ultimately transforming the results and return on investment from existing analytics and EHR systems.

Impact Biosystems

Seed Round in 2021
Impact Biosystems is a developer and creator of adaptive hardware and software solutions for people in the health and fitness space. The company offers hardware connected recovery platform that makes users feel better with custom measurements of their body and make the gamifying and socializing experience adapted to them, thereby enabling athletes of all varieties to uniquely feel better, perform at their peak, and help them live longer. Impact Biosystems' goal is to make athletes of all varieties uniquely feel better, perform at their peak and help them live longer. It was founded in 2020 and is headquartered in Boston, MA.

PulseData

Series A in 2021
pulseData, Inc. is a New York-based company founded in 2015 that specializes in developing machine learning software tailored for healthcare providers. The company's platform leverages adaptive and predictive data science tools to identify patients at risk of adverse medical outcomes, enabling healthcare organizations to deliver targeted care to those who need it most. By analyzing vast amounts of data, including individual patient information and population patterns, pulseData aids care management teams in providing timely and effective interventions. This approach not only enhances patient care but also aims to reduce preventable illnesses and optimize medical cost savings for healthcare enterprises.

Scipher Medicine

Series C in 2021
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.

Beam

Series E in 2021
Beam Technologies Inc. is a dental benefits company that focuses on integrating technology with oral hygiene. Founded in 2012 and based in Columbus, Ohio, the company has developed the Beam Brush, a wirelessly connected toothbrush that tracks users' brushing habits through a smartphone app. This data is utilized to inform insurance plan pricing, allowing individuals to potentially lower their premiums based on their dental hygiene practices. In addition to the smart toothbrush, Beam offers dental insurance plans that include benefits such as floss, toothpaste, and the Beam Brush itself. The company also provides a biannual subscription service that includes an electric toothbrush, replacement heads, toothpaste, and floss, simplifying access to dental care through a nationwide network of dentists.

Kenshō Health

Venture Round in 2021
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.

Conversa

Series B in 2021
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Ellipsis Health

Seed Round in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.

Beam

Venture Round in 2021
Beam Technologies Inc. is a dental benefits company that focuses on integrating technology with oral hygiene. Founded in 2012 and based in Columbus, Ohio, the company has developed the Beam Brush, a wirelessly connected toothbrush that tracks users' brushing habits through a smartphone app. This data is utilized to inform insurance plan pricing, allowing individuals to potentially lower their premiums based on their dental hygiene practices. In addition to the smart toothbrush, Beam offers dental insurance plans that include benefits such as floss, toothpaste, and the Beam Brush itself. The company also provides a biannual subscription service that includes an electric toothbrush, replacement heads, toothpaste, and floss, simplifying access to dental care through a nationwide network of dentists.

Levels

Seed Round in 2020
Levels Health Inc. is a New York-based company that specializes in health and wellness through its innovative biowearable device utilizing continuous glucose monitoring (CGM) technology. Founded in 2019, Levels offers a platform that tracks real-time blood glucose levels, allowing consumers to understand how their diet and exercise affect their metabolic health. Through its online application, the company provides users with actionable feedback to optimize their lifestyle choices for better metabolic fitness. As a remote-first organization, Levels aims to empower individuals to take charge of their health by leveraging technology to monitor and improve their metabolic well-being.

TwentyEight

Venture Round in 2020
TwentyEight Health, Inc. operates an online platform focused on women's reproductive and sexual health. Founded in 2018 and based in Brooklyn, New York, the company aims to enhance access to healthcare services, particularly in the area of birth control. It offers online doctor evaluations for birth control prescriptions, expedites home deliveries, and provides secure messaging with healthcare professionals. In addition to these services, TwentyEight Health features sex education content that is vetted by doctors, empowering women to understand their options regarding reproductive health. The platform is designed to provide a convenient and affordable way for women to access necessary healthcare services.

SHINE Technologies

Venture Round in 2020
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

Brio

Seed Round in 2020
Brio Systems, Inc. operates a comprehensive COVID-19 testing platform designed to assist employers in maintaining workplace safety through on-site testing. Founded in 2017 and based in Boston, Massachusetts, the company provides access to lab-backed polymerase chain reaction (PCR) and antibody testing, along with logistics support, medical oversight, and digital results communication within three days of test collection. Brio’s platform connects employers with FDA-certified laboratories, offering a turnkey solution that includes laboratory testing, fulfillment of collection kits, test requisitioning, medical supervision, and digital reporting. Serving various industries such as manufacturing and food processing, Brio Systems facilitates up to 50,000 tests daily, enabling businesses to protect their workforce and make informed risk-mitigation decisions.

Genome Medical

Venture Round in 2020
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Levels

Venture Round in 2020
Levels Health Inc. is a New York-based company that specializes in health and wellness through its innovative biowearable device utilizing continuous glucose monitoring (CGM) technology. Founded in 2019, Levels offers a platform that tracks real-time blood glucose levels, allowing consumers to understand how their diet and exercise affect their metabolic health. Through its online application, the company provides users with actionable feedback to optimize their lifestyle choices for better metabolic fitness. As a remote-first organization, Levels aims to empower individuals to take charge of their health by leveraging technology to monitor and improve their metabolic well-being.

Conversa

Venture Round in 2020
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Conversa

Series B in 2020
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Better Life Partners

Series A in 2020
We provide high quality and personalized health care for vulnerable populations - on their terms, where they are at. We’ve built technology that allows us to dynamically customize individual care plans and ensure reliable care delivery at scale, through telehealth, community-based, and digital modalities. By tightly integrating and coordinating medical and behavioral care we deliver superior value to patients and managed care organizations.

Glympse Bio

Venture Round in 2020
Glympse Bio, Inc. is focused on developing innovative diagnostic solutions that facilitate noninvasive monitoring of various diseases, including cancer, fibrosis, immunological disorders, and infectious diseases. The company employs modular nanoparticle sensors, utilizing precisely engineered diagnostic agents that assess disease states within the body and convey this information through urine analysis. This approach allows for predictive monitoring and evaluation of treatment responses. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's technology is rooted in research originally conducted at MIT and led by a team of experts in nanomedicine and biomedical engineering. Their flagship product, Glympse Inside, serves as a comprehensive platform for disease monitoring and aims to revolutionize how diseases are diagnosed and managed.

Brio

Venture Round in 2020
Brio Systems, Inc. operates a comprehensive COVID-19 testing platform designed to assist employers in maintaining workplace safety through on-site testing. Founded in 2017 and based in Boston, Massachusetts, the company provides access to lab-backed polymerase chain reaction (PCR) and antibody testing, along with logistics support, medical oversight, and digital results communication within three days of test collection. Brio’s platform connects employers with FDA-certified laboratories, offering a turnkey solution that includes laboratory testing, fulfillment of collection kits, test requisitioning, medical supervision, and digital reporting. Serving various industries such as manufacturing and food processing, Brio Systems facilitates up to 50,000 tests daily, enabling businesses to protect their workforce and make informed risk-mitigation decisions.

MD Ally

Pre Seed Round in 2020
MD Ally, Inc. is a telemedicine platform focused on enhancing emergency medical services (EMS) through innovative triage solutions. Established in 2020 and headquartered in Philadelphia, Pennsylvania, the company aims to bridge non-emergency care gaps by integrating telemedicine into emergency dispatch processes. This allows EMS personnel to effectively triage patients with non-life-threatening conditions, directing them to virtual medical and behavioral healthcare professionals, as well as follow-up care and social services. MD Ally's platform is designed collaboratively by EMS and emergency room practitioners, making it user-friendly for public safety entities. By providing this technology, MD Ally seeks to improve patient outcomes, reduce response times, and optimize the use of emergency resources, ultimately contributing to better overall healthcare delivery.

Mission Bio

Venture Round in 2020
Mission Bio, Inc. specializes in tools for studying cellular heterogeneity in human health and life science research. The company utilizes microfluidic droplet technology to provide solutions for molecular analysis at the single-cell level. Its flagship product, the Tapestri Platform, is the first single-cell multi-omics platform, allowing for the simultaneous detection of genotype and phenotype from the same cell, which enhances the understanding of disease progression and treatment responses. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating targeted single-cell DNA custom panels, applicable in various fields including oncology, blood cancers, solid tumors, and genome editing validation. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Thirty Madison

Venture Round in 2020
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.

Emulate

Series D in 2020
Emulate, Inc. specializes in developing organs-on-chips technology that emulates human biology to better understand the effects of diseases, medications, and environmental factors on human health. The company offers organ-chips that replicate the functions of various organs, including the lung, intestine, liver, and skin, and can simulate both normal and disease states. Emulate’s platform aims to provide more accurate predictions of human responses compared to traditional experimental methods, such as cell cultures or animal testing. The company serves a diverse clientele that includes biotechnology and pharmaceutical firms, consumer health and cosmetics companies, government agencies, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. It has shifted its focus towards advancing product innovation and safety across multiple sectors, including drug development and personalized medicine.

Emulate

Debt Financing in 2020
Emulate, Inc. specializes in developing organs-on-chips technology that emulates human biology to better understand the effects of diseases, medications, and environmental factors on human health. The company offers organ-chips that replicate the functions of various organs, including the lung, intestine, liver, and skin, and can simulate both normal and disease states. Emulate’s platform aims to provide more accurate predictions of human responses compared to traditional experimental methods, such as cell cultures or animal testing. The company serves a diverse clientele that includes biotechnology and pharmaceutical firms, consumer health and cosmetics companies, government agencies, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. It has shifted its focus towards advancing product innovation and safety across multiple sectors, including drug development and personalized medicine.

WelbeHealth

Series C in 2020
WelbeHealth is a healthcare organization dedicated to enhancing the quality of life for frail seniors through the PACE (Program of All-Inclusive Care for the Elderly) model. Founded by experienced physician entrepreneurs, the company provides comprehensive medical and social care, ensuring that participants receive coordinated support that includes medical and dental care, therapy services, transportation, and meal provisions. By focusing on the diverse needs of the elderly population, WelbeHealth aims to help them live longer, healthier, and more independent lives. The leadership team comprises professionals from prominent payer and provider organizations, reflecting a commitment to innovative and compassionate care. Through its holistic approach, WelbeHealth strives to unlock the potential of vulnerable seniors in the community, fostering an environment of empathy and support.

Asto CT

Venture Round in 2019
Asto CT LLC specializes in developing X-ray computed tomography (CT) systems specifically for equine imaging, aimed at enhancing the care and safety of thoroughbreds, show, recreational, and older horses. Founded in 2015 and based in Madison, Wisconsin, the company offers advanced imaging solutions that improve fracture risk detection, diagnose lameness, and address dental and sinus issues without the need for general anesthesia. Their flagship product, Equina, provides rapid 3D imaging of horses' lower limbs, head, and neck while ensuring a safe and comfortable environment for the animals. By integrating cutting-edge robotics with advanced multi-slice CT technology, Asto CT enhances veterinary diagnostics and treatment, particularly for conditions affecting the distal limb and diseases of the head and neck.

SQZ Biotech

Series D in 2019
SQZ Biotechnologies Company is a clinical-stage biotechnology firm based in Watertown, Massachusetts, focused on developing innovative cell therapies for cancer and other serious diseases. Its primary product candidate, SQZ-PBMC-HPV, is currently undergoing Phase I clinical trials as both a standalone treatment and in combination with other immuno-oncology agents for HPV16+ advanced or metastatic solid tumors. The company utilizes its proprietary CellSqueeze technology to deliver various materials into patient cells, aiming to engineer the immune system for both activation and suppression. Additionally, SQZ Biotech is advancing multiple platforms, including SQZ Activating Antigen Carriers and SQZ Tolerizing Antigen Carriers, to address diverse clinical challenges. Established in 2013, the company is dedicated to transforming cell therapies through internal research and strategic partnerships.

NeuroFlow

Series A in 2019
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.

Legacy

Seed Round in 2019
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.

Notable Labs

Venture Round in 2019
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.

Tembo Health

Venture Round in 2019
Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans.

Olaris

Venture Round in 2019
Olaris, Inc. is a biotechnology company based in Waltham, Massachusetts, focused on developing a precision medicine diagnostic platform aimed at improving disease diagnosis and treatment. Founded in 2013, Olaris specializes in metabolite profiling and personalized biomarkers of response, utilizing advanced machine learning algorithms. This innovative approach allows healthcare providers to identify the most effective treatments for individual patients, thereby optimizing clinical outcomes and minimizing adverse effects associated with therapies. Through its metabolomics platform, Olaris seeks to transform the way diseases, particularly breast cancer, are diagnosed and managed.

HENRY The Dentist

Series A in 2019
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Vincere Biosciences

Venture Round in 2019
Vincere Biosciences Inc is a biotechnology company based in Cambridge, Massachusetts, focused on developing small molecule therapeutics aimed at halting the progression of Parkinson's disease. Founded in 2018, the company utilizes proprietary simulation and artificial intelligence to transform discoveries into effective therapeutic programs. Its patented biology simulation technology integrates extensive human genomic and biochemical data, facilitating research and clinical studies. This innovative approach aims to restore mitochondrial quality and offers a pathway for medical researchers to access potential treatments for Parkinson's disease, enhancing the development of drugs designed to alleviate its impact. As a JLABS incubator company, Vincere is positioned at the forefront of neurodegenerative disease research.

Kenshō Health

Pre Seed Round in 2019
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.

Mighty Health

Seed Round in 2019
Mighty Technologies, Inc. is a company focused on developing a wellness application specifically designed for older adults, particularly those dealing with joint issues or other health challenges. Incorporated in 2018 and based in San Francisco, the company provides a personalized platform that connects users with coaches to foster the development of healthy habits related to nutrition and lifestyle. The application serves as a comprehensive resource, offering customizable exercise programs, nutrition guidance, and holistic health support. Additionally, it features a motivational community aimed at encouraging users to achieve their health goals through personal training and wellness coaching.

Mighty Health

Seed Round in 2019
Mighty Technologies, Inc. is a company focused on developing a wellness application specifically designed for older adults, particularly those dealing with joint issues or other health challenges. Incorporated in 2018 and based in San Francisco, the company provides a personalized platform that connects users with coaches to foster the development of healthy habits related to nutrition and lifestyle. The application serves as a comprehensive resource, offering customizable exercise programs, nutrition guidance, and holistic health support. Additionally, it features a motivational community aimed at encouraging users to achieve their health goals through personal training and wellness coaching.

Luma Health

Series B in 2019
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.

E25Bio

Seed Round in 2019
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Nurx

Series C in 2019
Nurx Inc. is a healthcare services company that operates a mobile health platform designed to provide easy access to a variety of everyday medications, including contraceptives, travel medications, and treatments for sexual health issues. The platform offers services such as doctor prescription and review, home HPV screening tests, and at-home STI testing. Users can manage their healthcare needs conveniently, with options for automatic prescription refills and renewals, all without the necessity of in-person consultations. Nurx aims to empower individuals, particularly women, by offering transparent pricing and judgment-free care, allowing them to take control of their health decisions. The company serves residents across multiple states, including California, Florida, New York, and Texas. Founded in 2015 and based in San Francisco, Nurx emphasizes personalized care through specialized providers and innovative technology.

Parachute Health

Venture Round in 2019
Parachute Health, LLC is a New York-based company founded in 2015 that specializes in developing a technology platform for ordering durable medical equipment. This platform is designed to enhance patient care by facilitating the efficient coordination of medical equipment and supplies. It integrates seamlessly with electronic medical record systems, allowing healthcare providers to prescribe orders electronically. The platform offers features such as real-time order status updates, digitized signatures, and integrated messaging, which streamline operations and reduce the need for manual data entry. Additionally, it notifies clinicians about patients' insurance qualifications for equipment, thereby improving delivery times for discharged patients. Parachute Health caters to healthcare facilities, providers, and suppliers, aiming to minimize errors and enhance the overall ordering process for medical equipment.

Legacy

Seed Round in 2019
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.

AdaptX

Venture Round in 2019
AdaptX operates a healthcare data analytics platform that focuses on delivering automated analytics to frontline clinical staff. Founded in 2016 and based in Seattle, the company emerged from Seattle Children's Hospital and serves hospitals and surgery centers. Through its innovative solutions, AdaptX empowers medical leaders and clinicians to access and analyze data effectively, enabling them to enhance clinical and workflow outcomes. This approach not only improves patient care but also helps reduce costs, thereby transforming clinical operations within the healthcare sector.

Scipher Medicine

Series B in 2019
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.

HENRY The Dentist

Series A in 2019
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Seed Health

Seed Round in 2019
Seed Health is a microbial sciences company focused on harnessing the applications of bacteria to enhance human and environmental health. Through collaborations with prominent academic institutions, the company accelerates scientific advancements to create live biotherapeutics and innovative consumer products. Its consumer brand, Seed®, specializes in developing next-generation probiotics tailored for various life stages and body ecosystems. The product offerings include supplements that combine probiotics and prebiotics aimed at providing systemic benefits, such as improving digestive health, skin health, heart health, and supporting micronutrient synthesis. The company's Scientific Advisory Board comprises experts in various fields, including microbiology, immunology, and gastroenterology, further strengthening its commitment to scientific rigor and innovation.

SleepSpace

Venture Round in 2018
SleepSpace, operated by Proactive Life, Inc., is focused on improving sleep health through innovative digital solutions. Based in New York, the company has developed a digital sleep assistant that utilizes advanced algorithms and wearable technology to accurately track sleep stages. This assistant aims to enhance regenerative rest and optimal alertness by providing real-time interventions using sound, light, and temperature adjustments. In addition to nightly interventions, SleepSpace connects users with coaches, clinicians, and corporate wellness programs by sharing personalized sleep data, addressing the widespread issue of poor sleep health that affects billions globally. The company's offerings also include applications like Sleep-2-Peek, which helps users identify their best mental and physical performance times, and MindMetrics, which measures cognitive alertness through engaging games.

Clear Labs

Series B in 2018
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.

Farcast

Series C in 2018
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.

Apprentice Health

Seed Round in 2018
ClearView MD is a predictive analytics firm that is powering the transition to value-based care by providing health systems interventions that lead to higher patient and staff satisfaction, lower costs, and the ability to treat more patients. ClearView MD identifies inefficiencies on client's workflows, and recommends steps to improve your scheduling, staffing, and facility utilization. The company was founded by Rajiv Sivendran and Artur Menzeleev, with headquarters in Boston, Massachusetts.

NeuroFlow

Venture Round in 2018
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.

Vital Plan

Venture Round in 2018
Vital Plan, Inc. specializes in producing natural supplements aimed at addressing various health conditions, including cardiovascular health, digestive issues, immune support, and stress management. Founded in 2008 and headquartered in Cary, North Carolina, the company aims to enhance transparency and credibility within the natural products industry, which has often faced criticism for misleading labeling and poor-quality ingredients. In addition to its range of supplements, Vital Plan offers guided educational wellness courses, health coaching, and physician-formulated supplement protocols to empower individuals on their health journeys. The company provides its products online, making them accessible to a broader audience seeking to improve their overall well-being.

Eva

Venture Round in 2018
Higia Technologies, founded in 2016 and based in Mexico City, has developed EVA, an accessible and non-invasive wearable device aimed at assessing breast cancer risk. The device features tactile sensors that map the surface of the breast and its surrounding areas, enabling women to monitor changes in breast temperature, size, and weight. Equipped with biosensors, EVA continuously collects and analyzes this information, providing users with a reliable tool for tracking their breast health.

HealthMyne

Series B in 2018
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative search, analytics, and imaging solutions primarily for cancer care providers. The company's smart imaging technology supports clinical decision-making by offering real-time, evidence-based insights that enhance diagnostic accuracy and foster collaboration among healthcare professionals. HealthMyne's platform includes features such as automatic tumor staging, dose overlays, specialized reporting, and management of incidental findings, all aimed at improving patient care and optimizing the efficiency of clinical workflows. By integrating electronic health record capabilities with advanced imaging solutions, HealthMyne seeks to reduce care delivery costs while ensuring that clinicians have access to relevant patient information for informed treatment decisions.

Farcast

Series C in 2018
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.

Lumiata

Series B in 2018
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

WelbeHealth

Series B in 2018
WelbeHealth is a healthcare organization dedicated to enhancing the quality of life for frail seniors through the PACE (Program of All-Inclusive Care for the Elderly) model. Founded by experienced physician entrepreneurs, the company provides comprehensive medical and social care, ensuring that participants receive coordinated support that includes medical and dental care, therapy services, transportation, and meal provisions. By focusing on the diverse needs of the elderly population, WelbeHealth aims to help them live longer, healthier, and more independent lives. The leadership team comprises professionals from prominent payer and provider organizations, reflecting a commitment to innovative and compassionate care. Through its holistic approach, WelbeHealth strives to unlock the potential of vulnerable seniors in the community, fostering an environment of empathy and support.

Bainbridge Health

Seed Round in 2018
Bainbridge Health, Inc. is a Philadelphia-based company that develops a clinical intelligence and data analytics platform focused on improving medication safety in hospital systems. Founded in 2016, the company provides solutions specifically for medication safety leaders, including an infusion pump management software known as InfusionWare. This platform allows clinicians to manage infusion data centrally, enhancing patient safety by streamlining data handling and reducing the likelihood of medication errors. Bainbridge Health’s vendor-agnostic approach eliminates the need for cumbersome data management practices, enabling hospitals to mitigate risks associated with medication errors while also lowering avoidable costs.

Heal

Series C in 2018
Heal, Inc. operates an on-demand healthcare platform that connects patients with licensed, background-checked pediatricians and family doctors for house calls and telemedicine services. Founded in 2014 and based in Los Angeles, the company offers its services across several states, including California, Georgia, Maryland, New Jersey, New York, Virginia, Washington, and the District of Columbia. Patients can schedule appointments through Heal's mobile application available on both the App Store and Google Play. The service is designed to provide timely and convenient medical care for various needs, including urgent care, primary care, and preventive care, with costs typically around $99 or covered by select insurance co-pays. Heal aims to enhance the patient experience by making quality healthcare more accessible while ensuring that doctors can practice medicine in a fulfilling way.

Honor

Series C in 2018
Honor Technology, Inc. operates an online platform that connects in-home caregivers with seniors and their families across several states, including California, Texas, New Mexico, Arizona, Ohio, and Michigan. Founded in 2014 and based in San Francisco, the company provides non-medical home care services aimed at helping older adults live safely and comfortably in their own homes. Honor leverages proprietary technology to screen and match caregivers with seniors based on their specific needs. The platform offers features such as the Honor Frame, which informs seniors about their caregivers and arrival times. Additionally, families can monitor caregiver activities and visit durations. By partnering with local agencies through the Honor Care Network, the company enhances caregiver recruiting, training, and scheduling, supporting a reliable and transparent care experience for older adults.

RubiconMD

Series B in 2018
RubiconMD, Inc. is a New York-based company that provides an online platform designed to facilitate communication between primary care clinicians and specialists through its eConsult service. This platform enables primary care providers to discuss cases with top specialists, thereby improving patient care and reducing costs. In addition to eConsults, RubiconMD offers a range of services, including a continuing medical education (CME) credit program, live and on-demand CME webinars, and RubiconRx, a clinical pharmacy platform that supports medication access for patients. The company also provides integration services for electronic health records, onboarding and implementation support, and clinician engagement. Founded in 2013, RubiconMD serves a diverse clientele that includes employers, community health centers, correctional health clinicians, health plans, health systems, and direct primary care practices.

SHINE Technologies

Series B in 2018
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

Accolade

Series F in 2018
Accolade, Inc. develops technology-driven solutions designed to assist individuals in navigating the complexities of the healthcare system and workplace benefits in the United States. The company provides a cloud-based platform that integrates support from a team of health assistants and clinicians, including nurses and behavioral health specialists, to offer personalized guidance. Primarily serving employers, Accolade enables employees and their families to access a centralized resource for their health and benefits needs. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, the company focuses on improving healthcare experiences, outcomes, and costs through personalized advocacy and engagement strategies.

Health Hero

Venture Round in 2018
Health Hero, Inc. is a wellness platform provider that offers customized health solutions for employees and their families globally. Founded in 2014 and based in Tampa, Florida, the company connects users through mobile devices and computers to deliver health risk assessments, biometric screenings, and cultural assessments. The platform targets various industries and promotes employee engagement by incorporating gamification elements, allowing users to earn rewards for completing health-related tasks. Additionally, Health Hero facilitates automated follow-up communications via phone and text, catering to the needs of payers, providers, employers, and individuals. By focusing on social determinants of health, Health Hero aims to foster a healthier lifestyle for its users through personalized and accessible programming.

DOTS

Venture Round in 2018
DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.

RubiconMD

Series B in 2018
RubiconMD, Inc. is a New York-based company that provides an online platform designed to facilitate communication between primary care clinicians and specialists through its eConsult service. This platform enables primary care providers to discuss cases with top specialists, thereby improving patient care and reducing costs. In addition to eConsults, RubiconMD offers a range of services, including a continuing medical education (CME) credit program, live and on-demand CME webinars, and RubiconRx, a clinical pharmacy platform that supports medication access for patients. The company also provides integration services for electronic health records, onboarding and implementation support, and clinician engagement. Founded in 2013, RubiconMD serves a diverse clientele that includes employers, community health centers, correctional health clinicians, health plans, health systems, and direct primary care practices.

HENRY The Dentist

Seed Round in 2017
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Lumiata

Series A in 2017
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

NeuroFlow

Seed Round in 2017
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.